About 1 600 reports

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Healthcare
  • Infectious Disease
  • Genetic Disorder
  • Research And Development
  • Reproductive Health
  • Genetic Testing
  • Cancer
  • World
  • China
  • Cancer Incidence

DNA Sequencing market is one of the high-growth prospect industries with potential opportunities throughout 2028. The DNA Sequencing Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by DNA Sequencing types, applications. Further, DNA Sequencing market size...

  • Marketing Research
  • Health Services
  • Diagnostics
  • World

Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and growing investment in R&D. The technological advancements...

  • Genome Sequencing
  • Molecular Diagnostics
  • World
  • Europe
  • North America
  • APAC
  • South America
  • Middle East
  • Africa
  • Gross Domestic Product
  • Health Expenditure

Abstract: - Global Biotechnology Instrumentation Market to Reach $62.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Biotechnology Instrumentation estimated at US$42.5 Billion in the year 2020, is projected to reach a revised size of US$62.4 Billion by 2027, growing at a CAGR of 5.6% over the analysis...

  • Biotechnology
  • Immunodiagnostics
  • World
  • China
  • United States

The global sepsis diagnostics market size is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9%. The demand is expected to grow due to the rising incidence of sepsis, a growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing availability of a wide variety...

  • Diagnostics
  • Blood Disease
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Surgical Procedures Performed
  • Mortality Rate

Abstract: - Global Veterinary Molecular Diagnostics Market to Reach $769 Million by 2027 - Amid the COVID-19 crisis, the global market for Veterinary Molecular Diagnostics estimated at US$468.5 Million in the year 2020, is projected to reach a revised size of US$769 Million by 2027, growing at a CAGR of 7.3% over...

  • Molecular Diagnostics
  • World
  • China
  • United States

KEY FINDINGS The global DNA sequencing market growth is estimated to progress at a CAGR of 17.05% during the forecast period, 2021-2028. The market growth drivers include prevailing cancer cases, genome mapping programs implementation, increasing need for DNA sequencing in animals & plant reproduction, liquid biopsy applications,...

  • Genomics
  • Drug Development
  • Molecular Biology
  • Genetic Testing
  • World
  • APAC

The Infectious Disease Diagnostics Market was estimated to be USD 38,480.89 million in 2021 and is poised to grow at a CAGR of 3.79% by 2027 to reach USD 50,345.74 million. The COVID-19 pandemic has significantly impacted the infectious disease diagnostics market. Increasing incidences of infection in COVID-19 patients is anticipated...

  • Infectious Disease
  • Diagnostics
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious...

  • Molecular Diagnostics
  • World
  • North America
  • Health Expenditure
  • Cancer Incidence

The Middle East and Africa molecular quality controls market is expected to reach US$ 12.52 million by 2028 from US$ 6.87 million in 2021; it is estimated to grow at a CAGR of 9.0% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel...

  • Infectious Disease
  • Molecular Diagnostics
  • Laboratory
  • In Vitro Diagnostics
  • Genetic Testing
  • Drug Development
  • Middle East
  • Africa
  • Health Expenditure
  • Direct Sales

The Global Carrier Screening Market size is expected to reach $2,501.94 million by 2027, rising at a market growth of 10.81% CAGR during the forecast period. Carrier screening refers to a type of testing procedure that allows an end-user to know if he/she has a gene for any kind of genetic disorder. Carrier screening is broadly implemented...

  • Healthcare
  • Molecular Diagnostics
  • Infectious Disease
  • World
  • United States
  • Health Provider Density

The North America molecular quality controls market is expected to reach US$ 155.61 million by 2028 from US$ 75.79 million in 2021; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the...

  • Infectious Disease
  • Molecular Diagnostics
  • Laboratory
  • Genetic Testing
  • Drug Development
  • North America
  • United States
  • Cancer Incidence
  • Direct Sales

The South and Central America molecular quality controls market is expected to reach US$ 22.84 million in 2028 from US$ 11.94 million in 2021; it is estimated to grow at a CAGR of 9.7% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases...

  • Molecular Diagnostics
  • Infectious Disease
  • Laboratory
  • Genetic Testing
  • Drug Development
  • Central America
  • Chronic Disease Prevalence
  • Diabetes Prevalence

The Asia Pacific molecular quality controls market is expected to reach US$ 72.07 million in 2028 from US$ 34.27 million in 2021; it is estimated to grow at a CAGR of 11.2% from 2021 to 2028. Factors such as burgeoning demand for personalized medicines, declining cost of sequencing procedures, and increasing prevalence of genetic diseases...

  • Infectious Disease
  • Molecular Diagnostics
  • Laboratory
  • Genetic Testing
  • Drug Development
  • APAC
  • Direct Sales
  • Chronic Disease Prevalence

The Europe molecular quality controls market is expected to reach US$ 109.59 million by 2028 from US$ 55.76 million in 2021; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth...

  • Infectious Disease
  • Molecular Diagnostics
  • Laboratory
  • Genetic Testing
  • Drug Development
  • Europe
  • Cancer Incidence
  • Medical Technology Density

The Global Molecular Quality Controls Market size is expected to reach $259.4 million by 2028, rising at a market growth of 6.6% CAGR during the forecast period. Molecular quality controls are used to assess the performance of molecular tests like leukocyte reduced apheresis platelet (LRAP) units, virus load assays, pathogen detection,...

  • Diagnostics
  • Infectious Disease
  • Laboratory
  • Molecular Diagnostics
  • In Vitro Diagnostics
  • World
  • United States
  • Europe
  • Drug Approval

2021 Global Molecular Diagnostics Market Assessment--Country Shares and Sales Segment Forecasts This report provides:Estimates of facilities performing DNA sequencing and molecular diagnostic testing in France, Germany, Italy, Japan, Spain, UK and USA.Five-year test volume and sales forecasts...

  • Molecular Diagnostics
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

Report Scope: This report provides an updated review of pharmacogenomics, including materials, equipment, and strategies, and identifies current and emerging applications for pharmacogenomic products. The analyst delineates the current market status for pharmacogenomics, defines trends, and presents growth forecasts...

  • Cardiovascular Disease
  • Managed Care
  • Dementia
  • Research And Development
  • Psychotic Disorder
  • Genetic Testing
  • World
  • United States

Carrier Screening Market by Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, and Others), and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices, and Others)- Global Opportunity Analysis and Industry Forecast, 2021-2030 The...

  • Genetic Disorder
  • Molecular Diagnostics
  • World
  • APAC

Global food authentication testing market is projected to grow at a CAGR of 6.95% during the forecast period, 2020-2025. - Amidst the growing prevalence of food frauds in the industry, including deliberate substitution of ingredients, misleading consumers with false claims, and disruptive labeling, consumers have become skeptical about...

  • Molecular Diagnostics
  • APAC
  • Europe
  • Africa
  • South America
  • South Africa
  • Food Production
  • Allergy Prevalence

Emerging Molecular Diagnostics Market: Innovative Technologies and Strategic Profiles of Leading Suppliers This report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips,...

  • Molecular Diagnostics

The molecular diagnostics market is projected to grow from US$ 16,258.97 million in 2021 to US$ 36,176.65 million by 2028; it is expected to grow at a CAGR of 12.1% during 2021–2028. The market growth is mainly attributed to an increase in demand for point-of-care devices, developments by market players, and a rise in the prevalence of associated...

  • Molecular Diagnostics
  • World
  • APAC
  • Europe
  • Middle East
  • Health Expenditure
  • Chronic Disease Prevalence

Molecular Diagnostics Market By Type (Instruments, Reagents, Software & Services), By Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Others), By Application (Infectious diseases, Oncology, Genetic testing, Blood screening, Others), By...

  • Molecular Diagnostics
  • World

2021 Molecular Diagnostics Market--SWOT Analysis of Leading Competitors, Supplier Shares and Sales Forecasts by Country This report provides: - Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA. The report is available by section, and...

  • Molecular Diagnostics
  • World

Next-generation Sequencing Informatics Market by Product (Data Analysis & Management Tools, NGS Informatics Services, and Primary and Secondary Data Analysis Tools), Application (Drug Discovery, Diagnostics, Biomarker Discovery, Precision Medicine, and Agriculture & Animal Research) and End User (Hospitals and Clinics, Academic and...

  • Molecular Diagnostics
  • World
  • APAC
  • Health Expenditure

The global pharmacogenomics market reached a value of US$ 6.6 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 11.3 Billion by 2027, exhibiting a CAGR of 9.3% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • HIV AIDS
  • Molecular Diagnostics
  • Genomics
  • Research And Development
  • World

In Vitro Diagnostics (IVD): Market Size From $84.50 billion in 2020, the global In Vitro Diagnostics (IVD) market is projected to reach $121.09 billion by 2028. Based on our analysis the market is expected to grow at a CAGR of 4.6% from 2020 - 2028 timeframe. Some of the prominent trends that the market is witnessing...

  • In Vitro Diagnostics
  • World
  • Birth Rate

2024 Molecular Diagnostics Market: Supplier Shares, Sales Forecasts and Facilities by Country This report provides: - Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA. The report is available by section, and can be customized to...

  • Molecular Diagnostics
  • World

The global carrier screening market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Pathology
  • Molecular Diagnostics
  • Genetic Disorder
  • Genomics
  • World

2024 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Facilities, Test Volumes, and Sales Forecasts by Country This report provides: - Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA. - Estimates of facilities...

  • Molecular Diagnostics
  • World